References
- Mathisen MS1, Jabbour E, Kantarjian HM. Treatment of adult acute lymphoblastic leukemia (ALL) with a focus on emerging investigational and targeted therapies. Oncology. 2012;26(9):851–859.
- Winograd B, Lippens RJ, Oosterbaan MJ, Dirks MJ, Vree TB, van der Kleijn E. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children. Eur J Clin Pharmacol. 1986;30(2):231–238.
- Takeuchi A, Masuda S, Saito H, Doi T, Inui K. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. Kidney Int. 2001;60(3):1058–1068.
- Pereira CN, Machado FR, Guimarães HP, Senna AP, do Amaral JL. Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients. Sao Paulo Med J. 2004;122(4):141–146.
- Thomas DM, Coles GA, Williams JD. What does the renal reserve mean? Kidney Int. 1994;45(2):411–416.